TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12421064

Group type: EXPERIMENTAL
Intervention: Spatial pooling of velocity information with object rotation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spatial pooling of velocity information with object translation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing number of objects in the scene
Number of subjects: 0
Study: 10357416

Group type: EXPERIMENTAL
Intervention: Positive family history of cancer
Number of subjects: 24848

Group type: COMPARATOR
Intervention: Family members of cases
Number of subjects: 24848

Group type: COMPARATOR
Intervention: Family relation to cases or controls
Number of subjects: 24848
Study: 7496681

Group type: EXPERIMENTAL
Intervention: Low dose craniospinal irradiation (25 Gy) followed by a boost to the posterior fossa (total dose 55 Gy)
Number of subjects: 22
Study: 2024540

Group type: EXPERIMENTAL
Intervention: Enalapril (2.5 mg)
Number of subjects: 1210

Group type: COMPARATOR
Intervention: Prazosin (0.5 mg)
Number of subjects: 1210
Study: 6177262

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 18
Study: 29451949

Group type: EXPERIMENTAL
Intervention: GSS6Fr (6 French Glidesheath Slender)
Number of subjects: 1836

Group type: COMPARATOR
Intervention: GS5Fr (standard 5 Fr Glidesheath)
Number of subjects: 1836

Group type: EXPERIMENTAL
Intervention: GSS6Fr
Number of subjects: 1836

Group type: EXPERIMENTAL
Intervention: Hemostasis time
Number of subjects: 1836
Study: 27608819

Group type: EXPERIMENTAL
Intervention: Contralaterally controlled functional electrical stimulation (CCFES)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Cyclic neuromuscular electrical stimulation (cNMES)
Number of subjects: 80
Study: 24709765

Group type: EXPERIMENTAL
Intervention: Health-related quality of life (HRQOL)
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Type of disorder and disease severity
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 644
Study: 22409153

Group type: EXPERIMENTAL
Intervention: Non-ablative 1550-nm fractional Er: glass laser
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ablative 2940-nm fractional Er: YAG laser
Number of subjects: 0
Study: 20023292

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg twice daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 18195565

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir monotherapy
Number of subjects: 136

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir plus zidovudine and lamivudine (triple-drug therapy)
Number of subjects: 136
Study: 16390349

Group type: EXPERIMENTAL
Intervention: MMX-budesonide tablets (9 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: MMX-budesonide tablets with food
Number of subjects: 12

Group type: COMPARATOR
Intervention: MMX-budesonide tablets without food
Number of subjects: 12
Study: 14599823

Group type: EXPERIMENTAL
Intervention: Transverse incision with direct closure
Number of subjects: 30

Group type: COMPARATOR
Intervention: Longitudinal incision with Z-plasty closure
Number of subjects: 30
Study: 10826387

Group type: EXPERIMENTAL
Intervention: Critical pathway for CEA care
Number of subjects: 54
Study: 8877080

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 345

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 345
Study: 2061981

Group type: EXPERIMENTAL
Intervention: Cancer Prevention Reminders, computer-generated lists of overdue screening tests, and smoking and dietary assessment and counseling, supplemented by cancer education materials
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 7113712

Group type: EXPERIMENTAL
Intervention: Alcohol (whisky)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cheap red wine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Good regular wines
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acetic acid
Number of subjects: 6
Study: 30794288

Group type: EXPERIMENTAL
Intervention: Microbiome signature analysis in prostate cancer samples
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hierarchical clustering analysis of microbiome signatures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCR and targeted next-generation sequencing (NGS) validation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCR validation of Helicobacter
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Viral and Helicobacter integrations
Number of subjects: 0
Study: 28216389

Group type: EXPERIMENTAL
Intervention: Verbal counselling (VC)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Trainhaler (TH)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Verbal counselling (VC) and Trainhaler (TH)
Number of subjects: 105
Study: 25899101

Group type: EXPERIMENTAL
Intervention: High-Intensity Intermittent Exercise Training (HIIT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Exercise Training (MICT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 30
Study: 23846995

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0
Study: 22728908

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diet therapy (Control)
Number of subjects: 60
Study: 19474114

Group type: EXPERIMENTAL
Intervention: Capecitabine combinations
Number of subjects: 1318

Group type: COMPARATOR
Intervention: 5-FU combinations
Number of subjects: 1318
Study: 18030331

Group type: EXPERIMENTAL
Intervention: Insulin detemir (D)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Human insulin (HI)
Number of subjects: 34
Study: 15020037

Group type: EXPERIMENTAL
Intervention: Finasteride for 7 years
Number of subjects: 18882

Group type: COMPARATOR
Intervention: Placebo for 7 years
Number of subjects: 18882
Study: 11824302

Group type: EXPERIMENTAL
Intervention: Combination therapy (locoregional thrombolysis and mechanical thrombectomy)
Number of subjects: 0
Study: 9488097

Group type: EXPERIMENTAL
Intervention: Lu 25-109 at 150 mg tid for 7 days (fixed-dose MTD)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Lu 25-109 at titrated doses (75 mg tid, 100%, 125%, and 150% of fixed dose MTD)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 8072071

Group type: EXPERIMENTAL
Intervention: 16 mg methylprednisolone plus 40 mg nifedipine daily (group 1)
Number of subjects: 86

Group type: COMPARATOR
Intervention: 16 mg methylprednisolone plus placebo daily (group 2)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Nifedipine and methylprednisolone (group 1)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (group 2)
Number of subjects: 86
Study: 3289932

Group type: EXPERIMENTAL
Intervention: Disopyramide
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Disopyramide (after conversion from placebo)
Number of subjects: 90
Study: 31474435

Group type: EXPERIMENTAL
Intervention: HIV risk reduction intervention targeting sexual risk behaviors
Number of subjects: 525

Group type: COMPARATOR
Intervention: Attention-matched control targeting other health behaviors
Number of subjects: 525
Study: 29195963

Group type: EXPERIMENTAL
Intervention: Sudoku design with 8 Sudoku 16×16 squares (4 randomized independently and 4 in reverse order)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Smaller testing sessions using Sudoku design
Number of subjects: 112
Study: 25096918

Group type: EXPERIMENTAL
Intervention: Pulsed irrigation enhanced evacuation (PIEE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Polyethylene glycol-electrolyte lavage solution (PEG; CoLyte)
Number of subjects: 24
Study: 23457903

Group type: EXPERIMENTAL
Intervention: Symbiot stent
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: BMS with FilterWire
Number of subjects: 90

Group type: COMPARATOR
Intervention: BMS without EPD (control group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study: 21957706

Group type: EXPERIMENTAL
Intervention: Self-control (SC) group decided when to stop practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Yoked group completed the same number of trials as their SC counterparts
Number of subjects: 0
Study: 19144444

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus platinum
Number of subjects: 2186

Group type: COMPARATOR
Intervention: Vinorelbine plus platinum
Number of subjects: 2186
Study: 17131847

Group type: EXPERIMENTAL
Intervention: Perindopril treatment
Number of subjects: 78
Study: 15126811

Group type: EXPERIMENTAL
Intervention: 20 mg trospium twice daily
Number of subjects: 523

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 523
Study: 11204096

Group type: EXPERIMENTAL
Intervention: Instructional biasing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Silent control conditions
Number of subjects: 0
Study: 9801884

Group type: EXPERIMENTAL
Intervention: Povidone-iodine 4% solution
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline irrigation
Number of subjects: 50
Study: 7831637

Group type: EXPERIMENTAL
Intervention: Inhaled lignocaine (20 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Adrenaline (400 micrograms)
Number of subjects: 10
Study: 3139811

Group type: EXPERIMENTAL
Intervention: 3o PDS (Polydioxanone) to fascia plus 3o Prolene to skin
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2o chromic catgut to fascia plus 3o silk to skin
Number of subjects: 40
Study: 28899262

Group type: EXPERIMENTAL
Intervention: Retrieval practice with discrepancy detection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with discrepancy detection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concurrent assessment of misinformation narratives
Number of subjects: 0
Study: 28209296

Group type: EXPERIMENTAL
Intervention: Intravenous mitomycin (12 mg/m2 on day 1) or intravenous cisplatin (60 mg/m2 on days 1 and 29), with intravenous fluorouracil (1000 mg/m2 per day on days 1-4 and 29-32) and radiotherapy (50.4 Gy in 28 daily fractions)
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy (fluorouracil and cisplatin)
Number of subjects: 940

Group type: COMPARATOR
Intervention: No maintenance chemotherapy
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Progression-free survival
Number of subjects: 940
Study: 26439877

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 μg Se as Se yeast) daily for 6 months
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 58
Study: 24268128

Group type: EXPERIMENTAL
Intervention: Preventive intervention consisting of six sessions of 90 minutes each.
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 160
Study: 21956384

Group type: EXPERIMENTAL
Intervention: Small-central lesions
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Large-central lesions
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: DBRFS (Disfigured/Bothersome/Repair Factor Score) for small-central to large-central lesions
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: DBRFS for small-central to large-peripheral lesions
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Overall attractiveness penalty
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Importance to repair
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All large lesions and small central lesions
Number of subjects: 45
Study: 18280967

Group type: EXPERIMENTAL
Intervention: Melaleuca alternifolia mixed with Coe‐Comfort
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Nystatin mixed with Coe‐Comfort
Number of subjects: 27

Group type: COMPARATOR
Intervention: Coe‐Comfort (Control Group)
Number of subjects: 27
Study: 17194267

Group type: EXPERIMENTAL
Intervention: Zonisamide (100-600 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 12749487

Group type: EXPERIMENTAL
Intervention: Permethrin-treated bed nets (ITNs)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Control villages
Number of subjects: 296
Study: 12489598

Group type: EXPERIMENTAL
Intervention: Enhanced external counterpulsation (EECP)
Number of subjects: 0
Study: 9530459

Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia with propofol and remifentanil
Number of subjects: 50

Group type: COMPARATOR
Intervention: Inhalational anaesthesia with desflurane and nitrous oxide
Number of subjects: 50
Study: 8030454

Group type: EXPERIMENTAL
Intervention: 20 micrograms ethinyl estradiol with 75 micrograms gestodene
Number of subjects: 53

Group type: COMPARATOR
Intervention: 20 micrograms ethinyl estradiol with 150 micrograms desogestrel
Number of subjects: 53
Study: 2690620

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 91

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 91

Group type: COMPARATOR
Intervention: Erythromycin
Number of subjects: 91
Study: 932317

Group type: EXPERIMENTAL
Intervention: Schizophrenic subjects
Number of subjects: 35

Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 35
Study: 30293107

Group type: EXPERIMENTAL
Intervention: 12-week mixed power training (MPT), three times/week, 75 min/session
Number of subjects: 2
Study: 28070784

Group type: EXPERIMENTAL
Intervention: Parent scaffolding and child emotion regulation (ER)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Parent co-regulation strategies
Number of subjects: 51
Study: 25472625

Group type: EXPERIMENTAL
Intervention: Self-affirmation intervention
Number of subjects: 0
Study: 23439658

Group type: EXPERIMENTAL
Intervention: High load resistance exercise (6-8 repetition maximum)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Low load resistance exercise (15-20 repetition maximum)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Comparison between high load and low load resistance exercise
Number of subjects: 17
Study: 21680536

Group type: EXPERIMENTAL
Intervention: Female patients with multiple myeloma
Number of subjects: 1960

Group type: COMPARATOR
Intervention: Male patients with multiple myeloma
Number of subjects: 1960
Study: 18058651

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 120

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 120
Study: 16019040

Group type: EXPERIMENTAL
Intervention: Word stem completion task with novel items
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Word stem completion task with repeated items
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (age-matched controls)
Number of subjects: 22
Study: 12848597

Group type: EXPERIMENTAL
Intervention: lercanidipine 10 mg once daily
Number of subjects: 110
Study: 10706056

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CSA)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Rapamycin (Control)
Number of subjects: 14
Study: 9483355

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (reviparin sodium, Clivarin) s.c. once daily with graduated elastic stockings (n = 359)
Number of subjects: 718

Group type: COMPARATOR
Intervention: Graduated elastic stockings only (n = 359)
Number of subjects: 718
Study: 8460391

Group type: EXPERIMENTAL
Intervention: Magnesium infusion (10 mg/kg body weight) administered 12 hours and 1 hour prior to operation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 29911893

Group type: EXPERIMENTAL
Intervention: Intensive Prevention Programme (IPP)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 310
Study: 29247148

Group type: EXPERIMENTAL
Intervention: Ixekizumab 80 mg every 2 weeks (IXEQ2W)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Ixekizumab 80 mg every 4 weeks (IXEQ4W)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE)
Number of subjects: 381

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 381

Group type: COMPARATOR
Intervention: Adalimumab (ADA) 40 mg Q2W
Number of subjects: 381
Study: 27160199

Group type: EXPERIMENTAL
Intervention: Salt restriction (6 weeks)
Number of subjects: 46
Study: 25248812

Group type: EXPERIMENTAL
Intervention: Percutaneous PFO closure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0
Study: 22769235

Group type: EXPERIMENTAL
Intervention: Intravenous alendronate (ALN) 900 µg every 4 weeks
Number of subjects: 325

Group type: COMPARATOR
Intervention: Oral alendronate (ALN) 35 mg once weekly
Number of subjects: 325
Study: 20410849

Group type: EXPERIMENTAL
Intervention: Physical activity interventions (various types, including supervised exercise, moderate- or high-intensity PA)
Number of subjects: 3289

Group type: COMPARATOR
Intervention: Control conditions (not specified)
Number of subjects: 3289
Study: 17931376

Group type: EXPERIMENTAL
Intervention: 90-minute group educational programme on breastfeeding
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study: 15923147

Group type: EXPERIMENTAL
Intervention: PBL group (n=104)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Control group (n=103)
Number of subjects: 207
Study: 12392381

Group type: EXPERIMENTAL
Intervention: Symptomatic group exposed to ragweed pollen until predetermined severities of AR symptoms were demonstrated.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Asymptomatic group not exposed to ragweed pollen, retaining a minimum symptom profile.
Number of subjects: 0
Study: 10359738

Group type: EXPERIMENTAL
Intervention: DDD pacing
Number of subjects: 48

Group type: COMPARATOR
Intervention: Pacing backup (AAI‐30)
Number of subjects: 48
Study: 8569943

Group type: EXPERIMENTAL
Intervention: Acetate dialysis
Number of subjects: 10
Study: 1936331

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Centrifugation/swim‐up
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Direct IP insemination or controlled ovarian hyperstimulation
Number of subjects: 79
Study: 7125768

Group type: EXPERIMENTAL
Intervention: Health education program
Number of subjects: 0
Study: 30809536

Group type: EXPERIMENTAL
Intervention: Training group (TG) - 15-week combined exercise programme (strength, aerobic fitness, stability, flexibility)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (CG) - No intervention
Number of subjects: 45
Study: 29072015

Group type: EXPERIMENTAL
Intervention: LI 18‐EA
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: LI 4‐PC 6‐EA
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: LI 4‐PC 6‐TAES
Number of subjects: 216

Group type: COMPARATOR
Intervention: GB 34‐EA
Number of subjects: 216

Group type: COMPARATOR
Intervention: non‐acupoint‐EA
Number of subjects: 216
Study: 26013711

Group type: EXPERIMENTAL
Intervention: Subcutaneous (SQ) insulin glargine in combination with intravenous (IV) insulin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous (IV) insulin (standard care control)
Number of subjects: 40
Study: 23353610

Group type: EXPERIMENTAL
Intervention: Carbohydrate loading with 18% carbohydrate beverage (375 mL between 9 pm and 12 pm, and 250 mL at 6:30 am)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (drank only water)
Number of subjects: 6
Study: 21207018

Group type: EXPERIMENTAL
Intervention: Isosorbide-SR 40 mg
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (methylprednisolone plus celecoxib without isosorbide-SR)
Number of subjects: 66
Study: 19273960

Group type: EXPERIMENTAL
Intervention: Fibrin glue plus 20 million ASCs
Number of subjects: 49

Group type: COMPARATOR
Intervention: Fibrin glue alone
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Fibrin glue plus 40 million ASCs (if healing not seen at eight weeks)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Quality of life scores
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: ASCs treatment
Number of subjects: 49
Study: 17496227

Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 110
Study: 14963845

Group type: EXPERIMENTAL
Intervention: Eurotest
Number of subjects: 60

Group type: COMPARATOR
Intervention: 7MT (seven-minute test)
Number of subjects: 60

Group type: COMPARATOR
Intervention: MMSE (mini-mental state examination)
Number of subjects: 60
Study: 11414343

Group type: EXPERIMENTAL
Intervention: Alcohol dependent patients (older group)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Alcohol dependent patients (younger group)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Nonalcoholic controls (older group)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Nonalcoholic controls (younger group)
Number of subjects: 226
Study: 9565444

Group type: EXPERIMENTAL
Intervention: Prophylactic surfactant treatment
Number of subjects: 154

Group type: COMPARATOR
Intervention: Rescue surfactant treatment
Number of subjects: 154
Study: 7932936

Group type: EXPERIMENTAL
Intervention: Hospital rehabilitation (mean of 12.9 days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ambulatory rehabilitation (mean of 11.9 days)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hospital rehabilitation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ambulatory rehabilitation
Number of subjects: 100
Study: 2905241

Group type: EXPERIMENTAL
Intervention: roxatidine acetate 150 mg once daily
Number of subjects: 363

Group type: COMPARATOR
Intervention: roxatidine acetate 75 mg twice daily
Number of subjects: 363
Study: 31010570

Group type: EXPERIMENTAL
Intervention: Topical menthol at different concentrations (liquid and gel formulations)
Number of subjects: 59
Study: 29415829

Group type: EXPERIMENTAL
Intervention: Turmeric
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 25245138

Group type: EXPERIMENTAL
Intervention: Intervention to increase perceived control (PC)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Intervention to increase intrinsic motivation (IM)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Intervention to decrease perceived control (PC)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Intervention to increase extrinsic motivation
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Combination of interventions to increase PC and IM
Number of subjects: 185
Study: 24093664

Group type: EXPERIMENTAL
Intervention: 20 mg/mL hyaluronic acid gel (VYC-20L)
Number of subjects: 282

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 282